Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas F Larson

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
The Journal of Extra-Corporeal Technology|April 9, 2008
Lusitropic effects of dobutamine in young and aged mice in vivoEmily D Hirleman, Qianli Yu, Douglas F Larson
Life Sciences|May 10, 2003
Heart disease, methamphetamine and AIDSQianli Yu, Douglas F Larson, Ronald R Watson
Perfusion|April 18, 2008
Mathematical modeling of buffers used in myocardial preservationJonathan R Triana, Mark Yanagihashi, Douglas F Larson
The Journal of Extra-Corporeal Technology|August 25, 2005
General anesthesia in cardiac surgery: a review of drugs and practicesCory M Alwardt, Daniel Redford, Douglas F Larson
Life Sciences|June 3, 2004
Modulation of iNOS activity in age-related cardiac dysfunctionBo Yang, Douglas F Larson, Ronald R Watson
The Journal of Extra-Corporeal Technology|September 1, 2004
Relationship of aging and cardiac IL-10Victoria Dotson, Katherine Horak, Cory Alwardt, et al.
Cardiovascular Toxicology|June 18, 2010
T lymphocyte regulation of lysyl oxidase in diet-induced cardiac fibrosisSherma Zibadi, Randy Vazquez, Douglas F Larson, et al.
Perfusion|July 18, 2007
Effect of angiotensin II on primary cardiac fibroblast matrix metalloproteinase activitiesLaura Buford Stacy, Qianli Yu, Katherine Horak, et al.
Perfusion|July 30, 2015
Reliability of the Thoratec HeartMate II flow measurements and alarms in the presence of reduced or non-existent flowSeana G Hall, Kayla Gardner, Douglas F Larson, et al.
The Journal of Extra-Corporeal Technology|April 21, 2004
TGF-beta1 overexpression: a mechanism of diastolic filling dysfunction in the aged populationDouglas F Larson, Rene Ingham, Cory M Alwardt, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
The Journal of Extra-Corporeal Technology|April 9, 2008
Lusitropic effects of dobutamine in young and aged mice in vivoEmily D Hirleman, Qianli Yu, Douglas F Larson
Life Sciences|May 10, 2003
Heart disease, methamphetamine and AIDSQianli Yu, Douglas F Larson, Ronald R Watson
Perfusion|April 18, 2008
Mathematical modeling of buffers used in myocardial preservationJonathan R Triana, Mark Yanagihashi, Douglas F Larson
The Journal of Extra-Corporeal Technology|August 25, 2005
General anesthesia in cardiac surgery: a review of drugs and practicesCory M Alwardt, Daniel Redford, Douglas F Larson
Life Sciences|June 3, 2004
Modulation of iNOS activity in age-related cardiac dysfunctionBo Yang, Douglas F Larson, Ronald R Watson
The Journal of Extra-Corporeal Technology|September 1, 2004
Relationship of aging and cardiac IL-10Victoria Dotson, Katherine Horak, Cory Alwardt, et al.
Cardiovascular Toxicology|June 18, 2010
T lymphocyte regulation of lysyl oxidase in diet-induced cardiac fibrosisSherma Zibadi, Randy Vazquez, Douglas F Larson, et al.
Perfusion|July 18, 2007
Effect of angiotensin II on primary cardiac fibroblast matrix metalloproteinase activitiesLaura Buford Stacy, Qianli Yu, Katherine Horak, et al.
Perfusion|July 30, 2015
Reliability of the Thoratec HeartMate II flow measurements and alarms in the presence of reduced or non-existent flowSeana G Hall, Kayla Gardner, Douglas F Larson, et al.
The Journal of Extra-Corporeal Technology|April 21, 2004
TGF-beta1 overexpression: a mechanism of diastolic filling dysfunction in the aged populationDouglas F Larson, Rene Ingham, Cory M Alwardt, et al.
Pageof 5